Fermentation-based animal protein alternatives are gaining traction, and Pacifico Biolabs is now better equipped to capitalize on that trend after securing $7.6M in Series A funding. The early-stage biotech company, with operations in Berlin and Leipzig, is on a mission to unlock the potential of fermentation to revolutionize the animal protein industry.
The capital infusion comes as the company, backed by some of Europe’s leading FoodTech and ClimateTech VC investors, continues to combine scientific and business skills to advance its mission.
.png&w=3840&q=75)
